DE60102160D1 - Von arylalkylaminen abgeleitete carbamate - Google Patents

Von arylalkylaminen abgeleitete carbamate

Info

Publication number
DE60102160D1
DE60102160D1 DE60102160T DE60102160T DE60102160D1 DE 60102160 D1 DE60102160 D1 DE 60102160D1 DE 60102160 T DE60102160 T DE 60102160T DE 60102160 T DE60102160 T DE 60102160T DE 60102160 D1 DE60102160 D1 DE 60102160D1
Authority
DE
Germany
Prior art keywords
arylalkylamine
carbamate derived
carbamate
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60102160T
Other languages
English (en)
Other versions
DE60102160T2 (de
DE60102160T3 (de
Inventor
Gallemi Carles Farrerons
Ruiz Juan Lorenzo Catena
Serrat Anna Fernandez
Bono Ignacio Jose Miquel
Lopez Dolors Balsa
Navarro Jose Ignacio Bonilla
Arnal Carmen Lagunas
Roca Carolina Salcedo
Garcia Andres Fernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
L V A T LAB SA
Laboratorios Salvat SA
Original Assignee
L V A T LAB SA
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8494130&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60102160(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by L V A T LAB SA, Laboratorios Salvat SA filed Critical L V A T LAB SA
Publication of DE60102160D1 publication Critical patent/DE60102160D1/de
Publication of DE60102160T2 publication Critical patent/DE60102160T2/de
Application granted granted Critical
Publication of DE60102160T3 publication Critical patent/DE60102160T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B27/00—Photographic printing apparatus
    • G03B27/02—Exposure apparatus for contact printing
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B27/00—Photographic printing apparatus
    • G03B27/02—Exposure apparatus for contact printing
    • G03B27/14—Details
    • G03B27/16—Illumination arrangements, e.g. positioning of lamps, positioning of reflectors
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B27/00—Photographic printing apparatus
    • G03B27/02—Exposure apparatus for contact printing
    • G03B27/14—Details
    • G03B27/30—Details adapted to be combined with processing apparatus
    • G03B27/303—Gas processing
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03D—APPARATUS FOR PROCESSING EXPOSED PHOTOGRAPHIC MATERIALS; ACCESSORIES THEREFOR
    • G03D13/00—Processing apparatus or accessories therefor, not covered by groups G11B3/00 - G11B11/00
    • G03D13/002—Heat development apparatus, e.g. Kalvar

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60102160T 2000-06-27 2001-06-25 Von arylalkylaminen abgeleitete carbamate Expired - Lifetime DE60102160T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES200001661 2000-06-27
ES200001661 2000-06-27
PCT/ES2001/000252 WO2002000652A1 (es) 2000-06-27 2001-06-25 Carbamatos derivados de arilalquilaminas
EP01943553A EP1300407B2 (de) 2000-06-27 2001-06-25 Von arylalkylaminen abgeleitete carbamate

Publications (3)

Publication Number Publication Date
DE60102160D1 true DE60102160D1 (de) 2004-04-01
DE60102160T2 DE60102160T2 (de) 2004-09-09
DE60102160T3 DE60102160T3 (de) 2012-05-03

Family

ID=8494130

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60102160T Expired - Lifetime DE60102160T3 (de) 2000-06-27 2001-06-25 Von arylalkylaminen abgeleitete carbamate
DE20122417U Expired - Lifetime DE20122417U1 (de) 2000-06-27 2001-06-25 Von Arylalkylaminen abgeleitete Carbamate

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE20122417U Expired - Lifetime DE20122417U1 (de) 2000-06-27 2001-06-25 Von Arylalkylaminen abgeleitete Carbamate

Country Status (30)

Country Link
US (2) US6916828B2 (de)
EP (1) EP1300407B2 (de)
JP (1) JP5046465B2 (de)
KR (1) KR100751981B1 (de)
CN (1) CN1227251C (de)
AP (1) AP1420A (de)
AT (1) ATE260277T1 (de)
AU (2) AU6610001A (de)
BG (1) BG66102B1 (de)
BR (1) BR0112297A (de)
CA (1) CA2414514C (de)
CR (1) CR6889A (de)
CZ (1) CZ294251B6 (de)
DE (2) DE60102160T3 (de)
DK (1) DK1300407T4 (de)
EA (1) EA005520B1 (de)
ES (1) ES2213703T5 (de)
HK (1) HK1054934A1 (de)
HU (1) HU229306B1 (de)
IL (1) IL153707A0 (de)
MX (1) MXPA03000141A (de)
NO (1) NO328499B1 (de)
OA (1) OA12300A (de)
PL (1) PL201530B1 (de)
PT (1) PT1300407E (de)
SI (1) SI1300407T2 (de)
TR (1) TR200400420T4 (de)
UA (1) UA72632C2 (de)
WO (1) WO2002000652A1 (de)
ZA (1) ZA200300644B (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
ES2213703T5 (es) * 2000-06-27 2011-11-02 Laboratorios S.A.L.V.A.T., S.A. Carbamatos derivados de arilalquilaminas.
EP1345937B1 (de) * 2000-12-22 2005-09-28 Almirall Prodesfarma AG Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
ES2266291T3 (es) 2000-12-28 2007-03-01 Almirall Prodesfarma Ag Nuevos derivados de quinuclidina y composiciones medicinales que los contienen.
CA2470567A1 (en) 2001-12-14 2003-06-26 Targacept, Inc. Methods and compositions for treatment of central nervous system disorders
CN1832948B (zh) * 2001-12-20 2011-06-15 基耶西药品股份公司 1-烷基-1-氮*双环[2.2.2]辛烷氨基甲酸酯衍生物及其用作蕈毒碱受体拮抗剂的用途
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2204295B1 (es) * 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
EP1546099B1 (de) 2002-07-08 2008-12-31 Ranbaxy Laboratories Limited 3,6-disubstituierte azabicyclo-3.1.0 hexan-derivate als muscarinische rezeptorantagonisten
EP1618091A1 (de) 2003-04-09 2006-01-25 Ranbaxy Laboratories, Ltd. Substituierte azabicyclohexanderivate als antagonisten von muscarinrezeptoren
NZ542952A (en) 2003-04-11 2008-11-28 Ranbaxy Lab Ltd Azabicyclo derivatives as muscarinic receptor antagonists
WO2004091597A2 (en) * 2003-04-15 2004-10-28 Pharmacia & Upjohn Company Llc Method of treating irritable bowel syndrome (ibs)
AR044519A1 (es) 2003-05-02 2005-09-14 Novartis Ag Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
ES2246170B1 (es) * 2004-07-29 2007-04-01 Almirall Prodesfarma, S.A. Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
US20090012116A1 (en) * 2005-07-11 2009-01-08 Naresh Kumar Muscarinic Receptor Antagonists
WO2007024814A1 (en) * 2005-08-22 2007-03-01 Targacept, Inc. HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
CA2625664C (en) 2005-10-21 2016-01-05 Novartis Ag Human antibodies against il13 and therapeutic uses
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
PT2322525E (pt) 2006-04-21 2013-12-26 Novartis Ag Derivados de purina para utilização como agonistas do recetor de adenosina a2a
EP1882691A1 (de) 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Chinuclidinderivate als M3 Antagonisten
CA2664378A1 (en) 2006-09-29 2008-04-03 Novartis Ag Pyrazolopyrimidines as pi3k lipid kinase inhibitors
AU2007342223B2 (en) 2007-01-10 2011-02-24 Irm Llc Compounds and compositions as channel activating protease inhibitors
RU2441868C2 (ru) 2007-02-09 2012-02-10 Астеллас Фарма Инк. Аза-кольцевое соединение с внутренним мостиком
ES2361595T3 (es) 2007-05-07 2011-06-20 Novartis Ag Compuestos orgánicos.
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
EP2217597B1 (de) 2007-10-01 2011-03-30 Comentis, Inc. 1h-indol-3-carbonsäure-chinuclidin-4-ylmethylesterderivate als liganden für den nikotinischen alpha-7-acetylcholinrezeptor zur behandlung von alzheimer-krankheit
EP2065385A1 (de) * 2007-11-28 2009-06-03 Laboratorios SALVAT, S.A. Stabiles Kristallinsalz aus (R)-3-Fluorphenyl-3,4,5-Trifluorbenzylcarbaminsäure 1-Azabiciyclo [2.2.2]oct-3-yl Ester
MX2010006421A (es) 2007-12-10 2010-06-25 Novartis Ag Compuestos organicos.
AU2009203693B2 (en) 2008-01-11 2012-06-07 Novartis Ag Pyrimidines as kinase inhibitors
EP2254598B1 (de) 2008-02-13 2013-07-10 Targacept, Inc. Kombination von alpha-7-nikotinagonisten und antipsychotika
US8268834B2 (en) 2008-03-19 2012-09-18 Novartis Ag Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
EP2300010B1 (de) 2008-06-10 2015-03-04 Novartis AG Pyrazinderivate als blockierer des epithelialen natriumkanals
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
TW201031406A (en) 2009-01-29 2010-09-01 Novartis Ag Substituted benzimidazoles for the treatment of astrocytomas
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
CA2770873A1 (en) 2009-08-12 2011-02-17 Novartis Ag Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
IN2012DN01961A (de) 2009-08-17 2015-08-21 Intellikine Llc
EP2467383A1 (de) 2009-08-20 2012-06-27 Novartis AG Heterocyclische oximverbindungen
WO2011050325A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
EP2563123B1 (de) 2010-04-30 2018-04-25 Merck Sharp & Dohme Corp. Neue beta-3-adrenerge rezeptoragonisten
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
EP2673277A1 (de) 2011-02-10 2013-12-18 Novartis AG [1, 2, 4] triazolo [4, 3]pyridazinverbindungen als inhibitoren dec-met-tyrosinkinase
JP5808826B2 (ja) 2011-02-23 2015-11-10 インテリカイン， エルエルシー 複素環化合物およびその使用
SG192795A1 (en) 2011-02-25 2013-09-30 Irm Llc Compounds and compositions as trk inhibitors
UY34305A (es) 2011-09-01 2013-04-30 Novartis Ag Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
ES2691650T3 (es) 2011-09-15 2018-11-28 Novartis Ag 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como inhibidores de tirosina quinasa c-Met
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
WO2013038390A1 (en) 2011-09-16 2013-03-21 Novartis Ag N-substituted heterocyclyl carboxamides
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
ES2558457T3 (es) 2011-09-16 2016-02-04 Novartis Ag Compuestos heterocíclicos para el tratamiento de fibrosis quística
US9174994B2 (en) 2011-11-23 2015-11-03 Intellikine, Llc Enhanced treatment regimens using mTor inhibitors
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
RU2660354C2 (ru) 2012-04-03 2018-07-05 Новартис Аг Комбинированные продукты, содержащие ингибиторы тирозинкиназ, и их применение
MA37975B2 (fr) 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
WO2014151147A1 (en) 2013-03-15 2014-09-25 Intellikine, Llc Combination of kinase inhibitors and uses thereof
JP6218940B2 (ja) * 2013-07-13 2017-10-25 ベイジン エフエスウェルカム テクノロジー ディベロップメント カンパニー リミテッド キニン系化合物、その光学異性体及びその製造方法と医薬用途
WO2015084804A1 (en) 2013-12-03 2015-06-11 Novartis Ag Combination of mdm2 inhibitor and braf inhibitor and their use
BR112016020199A8 (pt) 2014-03-07 2021-07-20 Biocryst Pharm Inc composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
PT3134396T (pt) 2014-04-24 2019-12-16 Novartis Ag Derivados de amino piridina como inibidores da fosfatidilinositol 3-quinase
PL3134395T3 (pl) 2014-04-24 2018-07-31 Novartis Ag Pochodne pirazyny jako inhibitory 3-kinazy fosfatydyloinozytolu
KR20160141855A (ko) 2014-04-24 2016-12-09 노파르티스 아게 포스파티딜이노시톨 3-키나제 억제제로서의 아미노 피라진 유도체
JP2017524736A (ja) 2014-07-11 2017-08-31 アルファーマゲン，エルエルシー アルファ７−ニコチン性アセチルコリン受容体活性を調節するためのキヌクリジン化合物
WO2016011658A1 (en) 2014-07-25 2016-01-28 Novartis Ag Combination therapy
CN107207510B (zh) 2014-07-31 2019-11-29 诺华股份有限公司 联合疗法
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods
CN113891744A (zh) 2019-06-10 2022-01-04 诺华股份有限公司 用于治疗cf、copd和支气管扩张的吡啶和吡嗪衍生物
KR20220052934A (ko) 2019-08-28 2022-04-28 노파르티스 아게 치환 1,3-페닐 헤테로아릴 유도체 및 질환 치료에서의 이의 용도
TW202140550A (zh) 2020-01-29 2021-11-01 瑞士商諾華公司 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
IL300090A (en) 2020-07-24 2023-03-01 Genzyme Corp Pharmaceutical preparations containing VENGLUSTAT

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3287471A (en) * 1964-05-05 1966-11-22 Searle & Co Pyrrolidinyl nu-phenyl-nu-benzylcarbamates
JPH0495071A (ja) * 1990-08-10 1992-03-27 Kyorin Pharmaceut Co Ltd カルバミン酸誘導体
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
EP0747355A4 (de) * 1994-02-10 1997-04-09 Yamanouchi Pharma Co Ltd Neue carbamate und diese enthaltende arzneimittel
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
JPH08198751A (ja) * 1995-01-19 1996-08-06 Yamanouchi Pharmaceut Co Ltd カルバメート誘導体
ES2213703T5 (es) * 2000-06-27 2011-11-02 Laboratorios S.A.L.V.A.T., S.A. Carbamatos derivados de arilalquilaminas.
EP1345937B1 (de) * 2000-12-22 2005-09-28 Almirall Prodesfarma AG Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
CN1832948B (zh) * 2001-12-20 2011-06-15 基耶西药品股份公司 1-烷基-1-氮*双环[2.2.2]辛烷氨基甲酸酯衍生物及其用作蕈毒碱受体拮抗剂的用途

Also Published As

Publication number Publication date
TR200400420T4 (tr) 2004-03-22
OA12300A (en) 2006-05-12
SI1300407T2 (sl) 2011-09-30
EP1300407B2 (de) 2011-06-08
EA200300072A1 (ru) 2003-06-26
EA005520B1 (ru) 2005-04-28
HUP0301414A3 (en) 2008-03-28
PT1300407E (pt) 2004-05-31
DE60102160T2 (de) 2004-09-09
NO328499B1 (no) 2010-03-01
HK1054934A1 (en) 2003-12-19
NO20026211L (no) 2003-02-26
MXPA03000141A (es) 2003-05-27
CZ294251B6 (cs) 2004-11-10
KR100751981B1 (ko) 2007-08-28
NO20026211D0 (no) 2002-12-23
ES2213703T5 (es) 2011-11-02
EP1300407A1 (de) 2003-04-09
AP1420A (en) 2005-05-30
WO2002000652A1 (es) 2002-01-03
CA2414514C (en) 2009-12-22
AP2003002722A0 (en) 2003-06-30
CR6889A (es) 2008-08-21
AU2001266100B9 (en) 2005-10-06
IL153707A0 (en) 2003-07-06
DE20122417U1 (de) 2005-08-04
HU229306B1 (en) 2013-10-28
ZA200300644B (en) 2004-02-10
BG66102B1 (bg) 2011-04-29
JP2004501916A (ja) 2004-01-22
CZ2003261A3 (cs) 2003-06-18
ES2213703T3 (es) 2004-09-01
BR0112297A (pt) 2003-05-06
ATE260277T1 (de) 2004-03-15
DK1300407T4 (da) 2011-09-05
HUP0301414A2 (hu) 2003-09-29
EP1300407B1 (de) 2004-02-25
US20040063950A1 (en) 2004-04-01
SI1300407T1 (en) 2004-06-30
KR20030022159A (ko) 2003-03-15
AU6610001A (en) 2002-01-08
JP5046465B2 (ja) 2012-10-10
US6916828B2 (en) 2005-07-12
CN1227251C (zh) 2005-11-16
AU2001266100B2 (en) 2005-06-30
US20040235887A1 (en) 2004-11-25
DE60102160T3 (de) 2012-05-03
US7115629B2 (en) 2006-10-03
BG107474A (en) 2003-09-30
CN1449396A (zh) 2003-10-15
DK1300407T3 (da) 2004-03-22
UA72632C2 (uk) 2005-03-15
PL201530B1 (pl) 2009-04-30
CA2414514A1 (en) 2002-01-03
PL359333A1 (en) 2004-08-23

Similar Documents

Publication Publication Date Title
DE60102160D1 (de) Von arylalkylaminen abgeleitete carbamate
DE69908185D1 (de) Therapeutisch nützliche arylalkylamine von spirofuropyridinen
AR028073A1 (es) Carbamatos azabiciclicos
ATE372174T1 (de) Spritzvorrichtung
DE60236733D1 (de) Isoliertes schwingungsgyroskop
DE60212275D1 (de) Wäschtrockner
ATE323706T1 (de) Pyrazolopyridazinderivate
DE60210107D1 (de) Elastische mischungen
NO20034949D0 (no) Sulfonamider
DE60127311D1 (de) Verbesserung von luftbleichkatalysatoren
FI20010922A (fi) Uusia vektoreita
NO20014597D0 (no) Fremgangsmåte
ATE392418T1 (de) Substituierte fluoralkoxyphenylsulfonylharnstoffe
DE60226240D1 (de) Beschleunigungsaufnehmer
FI20011300A (fi) Sprinkleri
ATE363925T1 (de) Haarwaschmittel
ITMI20000456V0 (it) Custodia perfezionata per rivoltella
NO20030868L (no) N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
DE50102328D1 (de) Feuchttücher (i)
DE60232960D1 (de) Mundharmonikakamm
DE60111415D1 (de) Nagelschneider
ID27331A (id) Pembuatan antibiotik-antibiotik ketolida karbamat
DE50203105D1 (de) Lagerung von entnahmeelementen
DE10295006D2 (de) Bauwerksabdichtung
DE60131852D1 (de) Sprühgerät

Legal Events

Date Code Title Description
8363 Opposition against the patent
R102 Epo decision maintaining patent in amended form now final

Ref document number: 1300407

Country of ref document: EP

R082 Change of representative

Ref document number: 1300407

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, 81925 MUENCHEN, DE